Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Hematology Conferences

USA & Americas
Asia Pacific & Middle East

Hematology Congress

About Conference


Conference Series LLC LTD welcomes every one throughout the world to attend “15th Global Hematology Congress” during September 20-21, 2018 in Oslo, Norway working under the Theme: Hematology: New Insights into Diagnosis and Treatment which incorporates provoke keynote presentations, Oral talks, Poster presentations and Exhibitions.

The main aim of Hematology Congress is to explore the new insights into the diagnosis and treatment in the field of hematology to all the haematologists, researchers, professors and young researches forum.

Hematology Congress is to gathering people in academia and society interested in hematology to share the latest trends and important issues relevant to our field/subject area. The scientific programme of the conference is broad and embraces different research aspects with focus on diagnosis, treatment and prevention in particular with a Tumour and medical interest. The conference will include invited speakers, oral presentations, poster session and the young scientist award.

Why to attend??

15th Global Hematology Congress during September 20-21, 2018 at Oslo, Norway is a unique platform to share the knowledge on current research. With individuals from around the globe concentrated on finding out about Hematology and its advances; this is your best chance to achieve the biggest collection of members from the Hematology people group. Direct introductions, convey data, meet with present and potential researchers, make a sprinkle with new medication improvements, and get name acknowledgment at this 2-day occasion. Incredibly famous speakers, the latest strategies, advancements, and the most current updates in Hematology are signs of this gathering.

Target Audience

·        Hematology Students, Scientists

·        Hematology Faculty

·        Hematology Researchers

·        Medical Colleges

·        Business Entrepreneurs

·        Hematology Associations and Societies

·        Training Institutes

·        Manufacturing Medical Devices Companies 

Sessions/Tracks

Track 1: Immunohematology:

Immunohematology is commonly referred as “Blood banking” is a branch of haematology that deals with the study of antigen-antibody reactions associated with blood transfusion. A person employed in the field of Immunohaematology is referred to as Immonohaematologist.

The duties of Immunohaematologist include:

  • Blood typing
  • Cross matching
  • Antibody identification

Track 2: Leukocytosis:

Leukocytosis refers to increase in the total number of white blood cells above the normal range in the blood. It is frequently a sign of an inflammatory response, most commonly due to infection. Leukocytosis is very commonly seen in the people with less immunity. Symptoms include: parasitic, fungal, viral or bacterial infection, hemorrhage, cancer and exposure to certain medications or chemicals including steroids.

There are five major types of Leukocytosis:

  • Neutrophilia
  • Lymphocytosis
  • Monocytosis
  • Eosinophilia
  • Basophilia

Track 3: Thrombocytopenia:

Deficiency of thrombocytes (platelets) in the blood is referred as thrombocytopenia. It may occur due to decreased production, increased destruction, medication induced and other causes such as snakebite, lyme disease, thrombocytapheresis, niacin toxicity. It can be diagnosed by complete blood test, kidney function test, liver enzymes, vitamin B12 levels and erythrocyte sedimentation rate (ESR).

Types of thrombocytopenia:

  • Idiopathic (or immune) thrombocytopenic purpura (ITP)
  • Thrombotic thrombocytopenic purpura (TTP)
  • Haemolytic uraemic syndrome (HUS)

Track 4: Myeloma:

Multiple myeloma or plasma cell myeloma is a cancer that arises from plasma cells (mature lymphocytes) a type of white blood cells. In myeloma plasma cells become abnormal, proliferate and from tumours that accumulate in the different parts of the body especially in the bone marrow and over the surface of bones. These cells release only one type of antibody known as paraprotein (which do not exhibit any useful function). Myeloma is diagnosed and monitored by measuring the levels of paraproteins.

Signs and symptoms include:

  • Bone pain
  • Anemia
  • Kidney failure
  • Infection
  • Neurologica symptoms

Track 5: Blood Transfusion:

It is a medical procedure in which donated blood is transfused to a recipient. It is a lifesaving safe procedure. Transfusions are used to treat various medical conditions such as iron deficiency anemia, sickle cell disease, severe bleeding- usually from surgery, childbirth or a serious accident. Either whole blood or blood components (red blood cells, white blood cells, plasma and clotting factors) are used depending on the condition of the patient.

Adverse effects:

  • Immunologic reaction
  • Infection
  • Inefficacy

Track 6: Anemia:

Decrease in haemoglobin level or red blood cells count in blood leads to Anaemia. The symptoms include: Irritability, Palpitations, Breathlessness, Tingling, Glossitis (inflammation or infection of the tongue), Angina, Angular cheilitis (inflammatory lesions at the mouth's corners), Poor appetite, Dysphagia due to formation of esophageal webs (Plummer-Vinson syndrome), numbness, or burning sensations, Restless legs syndrome. If left untreated it leads to heart failure, arrhythmias and frequent infections.

  • Aplastic anemia
  • Iron deficiency anemia
  • Vitamin deficiency anemia
  • Hemolytic anemias
  • Anemia of chronic disease
  • Anemias associated with bone marrow disease
  • Sickle cell anemia

Track 7: Thrombosis:

Thrombosis is the formation of blood clot in the blood vessel. Thrombosis is generally classified by the type of blood vessel affected and the precise location of the blood vessels or the organ supplied by it. The treatment of thrombosis depends on the type of blood vessel whether it is in a vein or an artery, person’s impact and the risk of complications from treatment.

Thrombosis is classified into 3 types: 

  • Venous thrombosis
  • Arterial thrombosis
  • Limb ischemia

Track 8: Biomarkers in Haematology and Oncology:

A cancer biomarker is a substance or gene which indicates the presence of cancer in the body that are particularly associated with genetic mutations, which determine whether individuals are susceptible to particular type of cancer.

  • Diagnostic Biomarker
  • Genetic markers
  • Tumour markers
  • Biomarker Discovery
  • Cancer biomarkers

Track 9: HIV/AIDS:

Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS). It harms the immune system by destroying the white blood cells that fight infection. A person with HIV infection may not notice any symptoms at the initial stage, followed by no symptoms for prolonged period. As the infection progress, there will be an increasing risk of common infections like tuberculosis and other opportunistic infections. Thrombocytopenia is often associated with HIV infection. HIV and SIV-associated thrombocytopenia arise through multiple mechanisms, including decreased platelet production, increased platelet destruction due to HIV-mimetic anti-platelet antibodies, and increased use of activated platelets.

HIV is transmitted through three main routes:

  • Sexual
  • Body fluids
  • Mother-to-child

Track 10: Lymphoma:

Lymphoma is a group of blood cancers that results from white blood cells called lymphocytes. The two major types of lymphomas are Hodgkin’s lymphoma and non- Hodgkin lymphoma. There are two major types of Hodgkin lymphoma: classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. The most common symptom include: swelling of lymph nodes, which causes a lump to form under the skin. Other symptoms of HD include night sweats, itchy skin, fever, fatigue, unintended weight loss, persistent cough, trouble breathing, chest pain, pain in the lymph nodes, after consuming alcohol, enlarged spleen.

  • Radiation Therapy
  • Targeted Therapy
  • Chemotherapy

Track 11: Hemochromatosis:

Hemochromatosis is a disease where excess iron is accumulated in the body by any cause. Commonly affected organs by hemochromatosis are heart, endocrine glands and liver. It can be diagnosed by Ferritin test, Liver function test, Iron test, UIBC, TIBC and Transferrin test. Hemochromatosis may present with the following clinical syndromes: Liver Cirrhosis, Arthritis, Testicular Failure, Joint and bone pain and Cardiomyopathy.

Types of Hemochromatosis:

  • Haemochromatosis type 1: "classical" haemochromatosis
  • Haemochromatosis type 2A: juvenile haemochromatosis
  • Haemochromatosis type 2B: juvenile haemochromatosis
  • Haemochromatosis type 3
  • Haemochromatosis type 4
  • Congenital atransferrinaemia (very rare)
  • Acaeruloplasminaemia (very rare)
  • GRACILE syndrome (very rare)
  • Neonatal haemochromatosis

Track 12: Stem Cell Therapy:

Stem cell therapy is the treatment where stem cells are used to prevent a disease or condition. Haematopoietic stem cells are usually derived from bone marrow, umbilical cord or peripheral blood. Bone marrow transplantation is widely used stem cell therapy. It may be autologous, allogeneic or syngeneic.

Applications of Stem Cell Therapy:

  • Brain and spinal cord injury
  • Neurodegeneration
  • Blood cell formation
  • Pancreatic beta cells
  • Orthopaedics
  • Wound healing
  • Infertility

Track 13: Blood Tests:

A scientific examination of a sample of blood, generally advised by the physician for the diagnosis of illness, for the detection and measurement of drugs, assess your general state of health, to assess the functioning of the certain organs such as liver and kidneys.

Types of blood test:

  • Complete Blood Count
  • Kidney Test: Renal Profile
  • Cholesterol Test: Lipid Profile
  • Blood Glucose Test
  • Liver Function Test
  • Blood Clotting Test

Track 14: Blood Products:

A blood product may be defined as a therapeutic substance that is acquired from human blood. Some of the blood products are: Whole blood - which is rarely used in transfusion medicine. Blood Components - Suspension of red blood cells, white blood cells and platelets. Plasma derivatives - Plasma proteins such as albumin, coagulation factor suspension and immunoglobulins.

Common uses of Blood and its Components:

  • Whole Blood - In massive blood loss cases
  • Platelets - dengue, leukemia and cancer patients
  • Red Blood Cells - anemia
  • Fresh Frozen Plasma - Replace clotting factors

Track 15: Hematology Nursing:

Hematology nurses are instructed to provide nursing care to patients with blood diseases or disorders. Duties of the hematology nurse include: Encounter patients with blood diseases i.e. leukemia, haemophilia, sickle cell anemia and lymphoma,Take medical histories, Perform exams, Diagnose and treat blood diseases. They have authority to write prescriptions and order diagnostic laboratory work. Hematology nursing is closely related to oncology nursing.

They may also assist with:

  • Blood Tests
  • Blood Transfusions
  • Research
  • Chemotherapy

Track 16: Pediatric Haematology:

It is a branch of medicine that deals with the cause, diagnosis, treatment and prevention of the diseases related to blood of infants, children and adolescents. Paediatric haematologists/oncologists are specially trained to treat children with blood disorders and cancer.

  • Thalassemia
  • Fanconi Anemia
  • Sickle Cell Disease
  • Congenital Amegakaryocytic Thrombocytopenia
  • Dyskeratosis Congenita
  • Pediatric anemia
  • Pediatric factor VII & XIII diseases
  • Hereditary disorders of red cells permeability
  • Pediatric myelodysplasia
  • Pediatric myelofibrosis

Track 17: Haematology and Pharma industry:

The overall market for the hematological pharmaceuticals in top point as it is as often as possible foreseen to be improved over two or three decades. According to the overall market master, the hematology cure and definite market is depended upon to create at the rate of 7.5% from 2015-2020. A portion of the best drug store enterprises creating Biological Drugs and Generic Drugs fuse. Takeda Oncology, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen bio tech, Pfizer, Bayer, Otsuka, Sanofi, Astellas, Eisai, AbbVie, Pharmacyclics, Merck KGaA and Incyte.

Track 18: Case reports and Epidemiology of Hematology & Hem-Oncology:

A case report is a complete report of the signs, symptoms, diagnosis, treatment and follow-up of an individual patient. Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they need facilitated recognition of recent diseases and adverse effects of treatments. Case reports facilitate understanding the clinical spectrum of unique or rare diseases, moreover as uncommon presentations of common diseases. Case reports might also have a task to play in guiding the personalization of treatments in clinical follow. For instance, Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia was suggested by the report of a specific case.

Market Analysis

The Americas commanded the largest share of 45% of the global hematology market at an estimated $2,160 million in 2015. Europe commanded the 2nd largest share 26% of hematology market at an estimated $300 million in 2015.

The worldwide hematology showcase is separated into hematology products & administrations. Hematology items advertise has been portioned into instruments and consumables. The hematology instruments advertise is additionally divided into analyzers and slide strainers/producers. While the hematology consumables advertise has been grouped into three noteworthy sections in particular; officials, stains, and controls and calibrators. Besides, in light of the end-clients, the worldwide hematology advertise has been divided into business associations, remain solitary healing centres, explore organizations, and clinical testing labs.

 

Various factors, for instance, improvement of the high throughput hematology analyzers, expanding appropriation of mechanized hematology instruments by diagnostics research centers, integration of fundamental stream cytometry procedures in current hematology analyzers, innovative headways and developments in high affectability purpose of-mind (POC) hematology testing are moving the development of the worldwide hematology analyzers and reagents advertise. Then again, moderate appropriation of the propelled hematology instruments in the rising economies, hematology item reviews, and the high cost of hematology analyzers are limiting the development of the worldwide market.

 

Starting at 2014, North America holds the biggest offer of the worldwide market, trailed by Europe. Be that as it may, the Asia-Pacific market is required to develop at most noteworthy CAGR of ~9.4% from 2014 to 2019. Various components including creating medicinal services foundation, the extensive patient populace, expanding subsidizing/venture toward the advancement of hematology items and developing a focal point of both worldwide and residential players on the Asia-Pacific nations are empowering the development of the market in the Asia-Pacific district.

To Collaborate Scientific Professionals around the World

Conference Date September 20-21, 2018

Speaker Opportunity

Past Conference Report

Supported By

Journal of Blood Disorders & Transfusion Journal of Blood & Lymph Journal of Stem Cell Research & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos